Cargando…

Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation

Background: Adenosine can cause dormant electrical conduction between the pulmonary vein and left atrium after pulmonary vein isolation (PVI). Adenosine can also induce atrial fibrillation (AF) during catheter ablation. However, the clinical outcomes and effects of additional ablation for the trigge...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yun Young, Shim, Jaemin, Kim, Yun Gi, Min, Kyongjin, Roh, Seung-Young, Kim, Jin Seok, Choi, Jong-Il, Kim, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570534/
https://www.ncbi.nlm.nih.gov/pubmed/36233544
http://dx.doi.org/10.3390/jcm11195679
_version_ 1784810134842638336
author Choi, Yun Young
Shim, Jaemin
Kim, Yun Gi
Min, Kyongjin
Roh, Seung-Young
Kim, Jin Seok
Choi, Jong-Il
Kim, Young-Hoon
author_facet Choi, Yun Young
Shim, Jaemin
Kim, Yun Gi
Min, Kyongjin
Roh, Seung-Young
Kim, Jin Seok
Choi, Jong-Il
Kim, Young-Hoon
author_sort Choi, Yun Young
collection PubMed
description Background: Adenosine can cause dormant electrical conduction between the pulmonary vein and left atrium after pulmonary vein isolation (PVI). Adenosine can also induce atrial fibrillation (AF) during catheter ablation. However, the clinical outcomes and effects of additional ablation for the trigger sites of adenosine-induced AF (AIAF) are unknown. This study therefore aimed to evaluate the clinical significance of AIAF. Methods: Between January 2010 and September 2019, we analyzed 616 consecutive patients with paroxysmal AF (PAF) who underwent radiofrequency catheter ablation (RFCA), including wide-area circumferential pulmonary vein isolation (PVI) and post-PVI adenosine testing. Results: Among 616 patients, 134 (21.7%) and 34 (5.5%) showed dormant conduction and AIAF, respectively. Eight patients (1.3%) had both dormant conduction and AIAF. The AF recurrence rate was not significantly different between patients with and without AIAF (16.7% vs. 18.6%, log-rank p = 0.827) during a mean follow-up period of 17.9 ± 18 months. Additional RFCA for the trigger site was attempted in 10 patients with AIAF; however, the recurrence rate of atrial arrhythmias was also not different between the groups with and without additional ablation (20% vs. 16.7%, log-rank p = 0.704). Conclusions: AIAF after PVI was not clinically associated with recurrence during long-term follow-up. Ablation of the trigger site in AIAF did not improve the clinical outcomes.
format Online
Article
Text
id pubmed-9570534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95705342022-10-17 Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation Choi, Yun Young Shim, Jaemin Kim, Yun Gi Min, Kyongjin Roh, Seung-Young Kim, Jin Seok Choi, Jong-Il Kim, Young-Hoon J Clin Med Article Background: Adenosine can cause dormant electrical conduction between the pulmonary vein and left atrium after pulmonary vein isolation (PVI). Adenosine can also induce atrial fibrillation (AF) during catheter ablation. However, the clinical outcomes and effects of additional ablation for the trigger sites of adenosine-induced AF (AIAF) are unknown. This study therefore aimed to evaluate the clinical significance of AIAF. Methods: Between January 2010 and September 2019, we analyzed 616 consecutive patients with paroxysmal AF (PAF) who underwent radiofrequency catheter ablation (RFCA), including wide-area circumferential pulmonary vein isolation (PVI) and post-PVI adenosine testing. Results: Among 616 patients, 134 (21.7%) and 34 (5.5%) showed dormant conduction and AIAF, respectively. Eight patients (1.3%) had both dormant conduction and AIAF. The AF recurrence rate was not significantly different between patients with and without AIAF (16.7% vs. 18.6%, log-rank p = 0.827) during a mean follow-up period of 17.9 ± 18 months. Additional RFCA for the trigger site was attempted in 10 patients with AIAF; however, the recurrence rate of atrial arrhythmias was also not different between the groups with and without additional ablation (20% vs. 16.7%, log-rank p = 0.704). Conclusions: AIAF after PVI was not clinically associated with recurrence during long-term follow-up. Ablation of the trigger site in AIAF did not improve the clinical outcomes. MDPI 2022-09-26 /pmc/articles/PMC9570534/ /pubmed/36233544 http://dx.doi.org/10.3390/jcm11195679 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Choi, Yun Young
Shim, Jaemin
Kim, Yun Gi
Min, Kyongjin
Roh, Seung-Young
Kim, Jin Seok
Choi, Jong-Il
Kim, Young-Hoon
Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title_full Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title_fullStr Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title_full_unstemmed Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title_short Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
title_sort clinical significance of adenosine-induced atrial fibrillation after complete pulmonary vein isolation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570534/
https://www.ncbi.nlm.nih.gov/pubmed/36233544
http://dx.doi.org/10.3390/jcm11195679
work_keys_str_mv AT choiyunyoung clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT shimjaemin clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT kimyungi clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT minkyongjin clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT rohseungyoung clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT kimjinseok clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT choijongil clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation
AT kimyounghoon clinicalsignificanceofadenosineinducedatrialfibrillationaftercompletepulmonaryveinisolation